Interactions of anticancer drugs with biomembranes: what can we learn from model membranes?

The interactions of anticancer drugs with cell membranes are of primary importance for drug transport, accumulation and activity. However, these interactions are very difficult to investigate because of the complexity of biological membranes. Lipid model membranes have therefore been built to gain i...

Full description

Saved in:
Bibliographic Details
Published in:Journal of controlled release 2014-09, Vol.190, p.127-138
Main Authors: Bourgaux, Claudie, Couvreur, Patrick
Format: Article
Language:English
Subjects:
Antineoplastic Agents - chemistry
Antineoplastic Agents - pharmacokinetics
Biological Transport - physiology
Cell Membrane - metabolism
Cell Membrane - ultrastructure
Drug Interactions
Membrane Lipids - metabolism
Models, Biological
Molecular Structure
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The interactions of anticancer drugs with cell membranes are of primary importance for drug transport, accumulation and activity. However, these interactions are very difficult to investigate because of the complexity of biological membranes. Lipid model membranes have therefore been built to gain insight into the collective role of lipids in drug-membrane interactions. Membranes can act as a barrier for drug molecules, sequester them or conversely may allow them to freely diffuse, thereby modulating the accumulation of drugs into cells. Lipid membranes also affect the ability of the efflux pump Pgp to bind and efflux anticancer drugs from cells. On the other hand, anticancer drugs can alter the structure and properties of lipid membranes, which are expected to influence the functioning of embedded proteins. The relevance of lipid model membranes to assess interactions between anticancer drugs and biomembranes is evidenced.
ISSN:0168-3659
1873-4995
DOI:10.1016/j.jconrel.2014.05.012